Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP3 | P08254 | 1/20 | 0.58 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.58 |
| ▸ | KIF11 | P52732 | 3/20 | 0.58 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | MAOA | P21397 | 1/20 | 0.52 |
| ▸ | MAOB | P27338 | 1/20 | 0.52 |
| ▸ | PGR | P06401 | 1/20 | 0.50 |
| ▸ | CYP11B2 | P19099 | 3/20 | 0.49 |
| ▸ | CYP11B1 | P15538 | 2/20 | 0.49 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | GCGR | P47871 | 2/20 | 0.46 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.46 |
| ▸ | MAPK13 | O15264 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | MAPK12 | P53778 | 1/20 | 0.46 |
| ▸ | MAPK11 | Q15759 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12444126 | 0.92 | — | — | |
| SCHEMBL39936 | 0.92 | — | — | |
| Water SCHEMBL28049243 | 0.92 | KDM4E (0.64) | MMP3PTGS1KIF11KDM4ETP53 | |
| Hydrochloric Acid SCHEMBL30942103 | 0.89 | KDM4E (0.61) | MMP3PTGS1KIF11KDM4ETP53 | |
| SCHEMBL7375936 | 0.89 | KDM4E (0.61) | MMP3PTGS1KIF11KDM4ETP53 | |
| SCHEMBL28783861 | 0.89 | KDM4E (0.61) | MMP3PTGS1KIF11KDM4ETP53 | |
| SCHEMBL28251780 | 0.89 | KDM4E (0.61) | MMP3PTGS1KIF11KDM4ETP53 | |
| Hydrogen Sulfide SCHEMBL9396299 | 0.89 | TSHR (0.52) | MMP3PTGS1KIF11KDM4ETP53 | |
| SCHEMBL23733812 | 0.87 | PGR (0.50) | MMP3PTGS1KIF11KDM4ETP53 | |
| SCHEMBL23733810 | 0.87 | PGR (0.50) | MMP3PTGS1KIF11KDM4ETP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022228449-A1 | PREPARATION METHOD FOR POLYIMIDE RESIN AND THIN FILM THEREOF | 上海瑞暨新材料科技有限公司 | 2022-11-03 | — | — | WO | claimed |
| CN-113201136-B | Preparation method of polyimide resin and film thereof | 上海瑞暨新材料科技有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-113201136-A | Preparation method of polyimide resin and film thereof | 上海瑞暨新材料科技有限公司 | 2021-08-03 | — | — | CN | claimed |
| US-20260124204-A1 | METALLOENZYME INHIBITOR COMPOUNDS | EIKONIZO THERAPEUTICS, INC. (US) | 2026-05-07 | — | — | US | disclosed |
| US-12370194-B2 | Metalloenzyme inhibitor compounds | EIKONIZO THERAPEUTICS, INC. (US) | 2025-07-29 | — | — | US | disclosed |
| US-20240307391-A1 | METALLOENZYME INHIBITOR COMPOUNDS | EIKONIZO THERAPEUTICS, INC. (US) | 2024-09-19 | — | — | US | disclosed |
| US-11938134-B2 | Metalloenzyme inhibitor compounds | EIKONIZO THERAPEUTICS, INC. (US) | 2024-03-26 | — | — | US | disclosed |
| WO-2023167325-A1 | IMMOBILIZED PALLADIUM CATALYST AND METHOD FOR PRODUCING SAME, AND APPLICATION OF THIS CATALYST TO COUPLING REACTION | 国立研究開発法人理化学研究所 | 2023-09-07 | — | — | WO | disclosed |
| WO-2022228449-A1 | PREPARATION METHOD FOR POLYIMIDE RESIN AND THIN FILM THEREOF | 上海瑞暨新材料科技有限公司 | 2022-11-03 | — | — | WO | disclosed |
| US-20220088018-A1 | METALLOENZYME INHIBITOR COMPOUNDS | EIKONIZO THERAPEUTICS, INC. (US) | 2022-03-24 | — | — | US | disclosed |
| CN-113201136-B | Preparation method of polyimide resin and film thereof | 上海瑞暨新材料科技有限公司 | 2022-01-07 | — | — | CN | disclosed |
| US-20120165343-A1 | Glucagon Receptor Modulators | PFIZER INC. (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120165343-A1 | Glucagon Receptor Modulators | PFIZER INC. (US) | 2012-06-28 | — | — | US | disclosed |
| US-20120165343-A1 | Glucagon Receptor Modulators | PFIZER INC. (US) | 2012-06-28 | — | — | US | disclosed |
| CN-101857517-A | Method for preparing fluorobiaryl compound in pure water solution | UNIV DALIAN TECH | 2010-10-13 | — | — | CN | disclosed |
| US-7521581-B2 | Catalyst composition and process for producing cross-coupled compound using same | TOSOH CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| US-7521581-B2 | Catalyst composition and process for producing cross-coupled compound using same | TOSOH CORPORATION (JP) | 2009-04-21 | — | — | US | disclosed |
| US-6242654-B1 | REACTING A PHENOLATE COMPOUND WITH AN ORGANIC FLUORINATING AGENT TO PREPARE A FLUORINE SUBSTITUTED AROMATIC COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2001-06-05 | — | — | US | disclosed |
| EP-1013629-A1 | Preparation process of fluorine subsituted aromatic compound | Mitsui Chemicals, Inc. (JP) | 2000-06-28 | — | — | EP | disclosed |
| EP-0733692-A1 | Liquid crystalline compound, liquid crystal composition containing the same, and display device | Chisso Corporation (JP) | 1996-09-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240307391-A1 | METALLOENZYME INHIBITOR COMPOUNDS | HDAC6, HDAC1, HDAC2 | MMP3 74/4885PTGS1 2083/4885KIF11 1264/4885 |
| US-20220088018-A1 | METALLOENZYME INHIBITOR COMPOUNDS | HDAC6, HDAC1, HDAC2 | MMP3 74/4885PTGS1 2083/4885KIF11 1264/4885 |
| US-20260124204-A1 | METALLOENZYME INHIBITOR COMPOUNDS | HDAC6, HDAC3, HDAC1 | MMP3 206/4885PTGS1 4313/4885KIF11 1009/4885 |
| US-20120165343-A1 | Glucagon Receptor Modulators | GLP1R, GCGR, GPR119 | MMP3 3485/4885PTGS1 706/4885KIF11 4048/4885 |
| US-11938134-B2 | Metalloenzyme inhibitor compounds | HDAC6, HDAC1, HDAC2 | MMP3 74/4885PTGS1 2083/4885KIF11 1264/4885 |
| US-12370194-B2 | Metalloenzyme inhibitor compounds | HDAC6, HDAC1, HDAC2 | MMP3 74/4885PTGS1 2083/4885KIF11 1264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.